Skip to main content
Clinical Trials/NCT02958059
NCT02958059
Unknown
Not Applicable

Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient

Yonsei University1 site in 1 country400 target enrollmentDecember 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Biliary Obstructive Disease Such as Choledocholithiasis
Sponsor
Yonsei University
Enrollment
400
Locations
1
Primary Endpoint
Rate of complication that related with infection.
Last Updated
7 years ago

Overview

Brief Summary

Endoscopic retrograde cholangio-pancreatography (ERCP) is advanced endoscopic technique that allows minimally invasive management of biliary and pancreatic disorders. However, the incidence of infectious complication of ERCP is considerable. Transient blood stream infection after ERCP has been reported in a high ratio, up to 27% and post-ERCP infection accounts for about 10% of the major complications associated with mortality.

Although prophylactic use of antibiotics is generally not recommend in all cases, debates about the prophylactic use of antibiotics continues and prophylactic use of antibiotics is recommend in case of ERCP that incomplete biliary drainage is expected.

In this study, researchers will use prophylactic antibiotics in patients with biliary obstruction who have high-risk of post-ERCP bacteremia. Antibiotics regimen is selected based on the data of our institution, and administered to patients before ERCP procedure.

Registry
clinicaltrials.gov
Start Date
December 1, 2016
End Date
August 2020
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with biliary obstructive disease (Benign or Malignant)
  • 19 year-old and older than 19 year-old

Exclusion Criteria

  • Younger than 19 year-old
  • Patients with leukocytosis (WBC ≥ 11,000/mm3)
  • Body temperature ≥ 38 °C within 72 hours before ERCP
  • History of antibiotics administration due to cholangitis, cholecystitis or sepsis within 72 hours before ERCP
  • Pregnancy women
  • Patients with allergy to beta-lactam

Outcomes

Primary Outcomes

Rate of complication that related with infection.

Time Frame: within 10 days

Secondary Outcomes

  • Rate of post-ERCP cholangitis(within 10 days)
  • Grade of post-ERCP infectious complication(within 10 days)

Study Sites (1)

Loading locations...

Similar Trials